|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 49 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
925,000 |
5,074,611 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2012-01-05 |
4 |
A |
$25.18 |
$27,124,526 |
I/I |
1,077,225 |
5,077,676 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-25 |
4 |
B |
$23.89 |
$843,196 |
I/I |
35,078 |
5,093,345 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2006-03-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,094,924 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-28 |
4 |
B |
$25.04 |
$1,058,018 |
I/I |
42,156 |
5,135,501 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-01 |
4 |
B |
$25.54 |
$1,104,574 |
I/I |
43,212 |
5,178,713 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-02 |
4 |
B |
$26.00 |
$1,956,372 |
I/I |
74,969 |
5,253,682 |
2.25 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2011-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,786 |
5,266,568 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-08 |
4 |
B |
$10.00 |
$5,237,901 |
I/I |
482,798 |
5,270,518 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-04 |
4 |
B |
$25.44 |
$1,282,845 |
I/I |
50,400 |
5,304,082 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-09 |
4 |
B |
$10.94 |
$991,319 |
I/I |
90,591 |
5,361,109 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-10 |
4 |
B |
$11.01 |
$13,657 |
I/I |
1,241 |
5,362,350 |
2.17 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-04-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,377,710 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-07-09 |
4 |
A |
$0.00 |
$0 |
I/I |
1,916,150 |
5,390,969 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-11 |
4 |
B |
$10.94 |
$335,548 |
I/I |
30,682 |
5,393,032 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-14 |
4 |
B |
$10.99 |
$380,398 |
I/I |
34,621 |
5,427,653 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-22 |
4 |
B |
$10.62 |
$2,368 |
I/I |
223 |
5,427,876 |
2.17 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-04-26 |
4 |
B |
$2.05 |
$208,007 |
I/I |
100,853 |
5,478,563 |
1.5 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-04-27 |
4 |
B |
$2.06 |
$106,340 |
I/I |
51,172 |
5,529,735 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
officerTitle |
|
2006-03-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,590,488 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-07 |
4 |
B |
$24.90 |
$7,430,585 |
I/I |
297,340 |
5,601,422 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-08 |
4 |
B |
$25.13 |
$45,887 |
I/I |
1,826 |
5,603,248 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-09 |
4 |
B |
$26.17 |
$1,333,262 |
I/I |
50,856 |
5,654,104 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-10 |
4 |
B |
$25.56 |
$511,150 |
I/I |
20,000 |
5,674,104 |
2.25 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-04-28 |
4 |
B |
$1.82 |
$278,647 |
I/I |
146,944 |
5,676,679 |
1.5 |
- |
|
1397 Records found
|
|
Page 49 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|